Skip to main content

Exscientia plc (EXAI)

Exscientia will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Market Capn/a
Revenue (ttm)14.49M
Net Income (ttm)-54.08M
Shares Outn/a
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Est. Earnings Daten/a

About EXAI

Exscientia is an artificial intelligence-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Our goal is to change the pharmaceutical industry’s underlying pharmacoeconomic model, what we call "Shifting the Curve", by improving the probability of success, time and cost involved with creating new medicines. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates. We have built a comple...

IndustryBiological Products
IPO DatePending
CEOAndrew L. Hopkins, DPhil
Stock ExchangeNASDAQ
Ticker SymbolEXAI
Full Company Profile

Financial Performance

In 2020, Exscientia's revenue was 9.67 million, an increase of 6.20% compared to the previous year's 9.11 million. Losses were -22.28 million, 252.7% more than in 2019.

Financial numbers in millions GBPFinancial Statements


Exscientia IPO Registration Document (S-1)

Exscientia plc has filed to go public with an IPO on the NASDAQ.

1 week ago - SEC

Bill and Melinda Gates back UK A.I. start-up developing antiviral drugs to prevent pandemics

Bill and Melinda Gates have backed a U.K. start-up called Exscientia that's trying to design new drugs with artificial intelligence software.

1 week ago - CNBC

UK's Exscientia, Gates Foundation partner to develop variant-resistant COVID-19 drugs

The Bill & Melinda Gates Foundation would make a $35 million equity investment in privately owned Exscientia Ltd to fund the development of antiviral drugs including for the coronavirus, the Oxford-...

2 weeks ago - Reuters